CDP791
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Oncology | Phase 2 |
C79102
Completed |
NCT00152477 2005-001731-30 |
Choose a Country
- Global Site – English
- Australia – English
- België – Engels
- Belgique – Anglais
- Brasil – Português
- България – Български
- Canada – English
- Canada – Français
- 中国 – 中文
- Česká Republika – Angličtina
- Danmark – Engelsk
- Deutschland – Deutsch
- France – Français
- España – Español
- Ελλάδα – Ελληνικά
- India – English
- Ireland – English
- Italia – Inglese
- 日本 – 日本語
- 한국 – 한국어
- Luxembourg – Anglais
- Luxemburg – Engels
- Magyarország – Angol
- México & Latinoamérica – Español
- Nederland – Engels
- New Zeeland – English
- Norge – Engelsk
- Österreich – Deutsch
- Polska – Polski
- Portugal – Inglês
- România – Engleză
- Россия – Русский
- Slovensko – Anglický
- Suomi – Englanti
- Sverige – Engelska
- Schweiz – Deutsch
- Türkiye – Türkçe
- Україна – Англійська
- United Kingdom – English
- U.S.A. – English
Our Company
Disease Areas
Our Science
Our Products
Newsroom
Patients
Investors
Clinical Studies
Advantage Hers
- Advantage Hers English
- Advantage Hers German
- Advantage Hers French
- Advantage Hers Spanish
- Advantage Hers Italian
- Advantage Hers Danish
- Advantage Hers Dutch
- Advantage Hers Polish
- Advantage Hers Greek
- Advantage Hers Finnish
- Advantage Hers Norwegian
- Advantage Hers Romanian
- Advantage Hers Bulgarian
- Advantage Hers Czech
- Advantage Hers Slovak
- Advantage Hers Australia
- Advantage Hers Canada